Hebrew University of Jerusalem, Israel
Professor of Biochemistry and Bioinformatics at the Hebrew University of Jerusalem (HUJI).[3] Linial is the Director of The Sudarsky Center for Computational Biology at HUJI.[4][5] Since 2015, she is head of the ELIXIR-Israel node (European life-sciences Infrastructure for biological Information).[6]Linial was elected a fellow of the International Society for Computational Biology (ISCB) in 2016, for outstanding contributions to the fields of computational biology and bioinformatics, and served on the Board of Directors (2005–2016), and as a Vice-President (2007–2016), of the ISCB Hebrew University,
University of Freiburg, Germany.
Nabil Djouder, born in France, obtained his PhD in Molecular Pharmacology from the University of Strasbourg (France) and the University of Freiburg (Germany), where he worked in the laboratory of K. Aktories. He studied the molecular mechanisms underlying the activation of mast cells by cross-linking high affinity antigen receptors (Fcε-RI) and the involvement of small GTPases from the Rho family in this activation.
In 2001, he moved to Basel (Switzerland) as a postdoctoral research fellow and joined the laboratory of W. Krek at the Novartis Friedrich Miescher Institute. He has since worked in the field of growth control, cancer, and associated metabolic disorders. Most of his research focuses on the mTOR/S6K pathway and the integration of growth factors, nutrients, and energy homeostasis.
University of Colorado, US
1972 – Ph.D. Univ. of Colorado.
1978 – Present, Lecturer, Senior Lecturer; Associate Professor; Professor.
1991 – Present, Professor (Adjunct); Department of Pharmacology, Duke University Medical School, Durham, North Carolina, USA
weizmann institute of science, Isreal
Rony continues to work in field of MAPK signaling and his achievements include: 1) Development of the first anti phospho antibodies for the study of MAPK activity; 2) Identification and study the role of alternatively spliced isoforms of ERKs; and 3) Elucidation of mechanisms that govern the subcellular localization of MAPK components, in particular their mechanism of nuclear translocation. 4) Use of the nuclear translocation as anti cancer and inflammation target.
He got Excellent Research Award of HKUST School of Engineering in 2012. He obtained Gold Medal and The Best Award in the Invention & Innovation Awards 2014 held at the Malaysia Technology Expo (MTE) 2014, which was hosted in Kuala Lumpur, Malaysia, on 20-22 Feb 2014. He is a Member of EU Academy of Sciences (EUAS) since July 2017.
Martin-Luther-University Halle-Wittenberg, Germany
Studies in Pharmacy at the Free University, Berlin, Germany, Practical training for pharmacists according to German law (AAppO) in two pharmacological groups at the Welsh School of Pharmacy, Cardiff, UK, and in a local pharmacy (Prenz’l-Apotheke), Berlin, Germany; Licensure as Pharmacist
Churchill Hospital, Headington, Oxford, UK
I qualified as a doctor at Charing Cross Hospital Medical School and trained in Medical Oncology at the Royal Marsden Hospital London and Churchill Hospital Oxford. Following a PhD with Alan Ashworth at Chester Beatty Laboratories in London, my postdoctoral training was supported by MRC Clinician Scientist and Cancer Research UK Senior Clinical Fellowships and HEFCE Clinical Senior Lectureship. I was Associate Professor and Honorary Consultant in Medical Oncology, Department of Oncology, University of Oxford from 2001 to 2021, now Emeritus Associate Professor, Nuffield Department of Surgical Sciences, University of Oxford. My laboratory research group uses basic, translational and clinical research to investigate the role of IGFs in prostate cancer and is supported by collaborating
Professor and Head, Department of Pharmacy Chaitanya Deemed to be University, Gandipet, Himayatnagar,
I am working as a Professor and HOD, Department of Pharmaceutical Analysis, Chaitanya Deemed to be University,Hanamkonda,Telangana
